Article | Published:

National incidence of eyelid cancer in Ireland (2005–2015)



We report on the incidence of cutaneous eyelid tumours in Ireland over the 11-year-period from 2005 to 2015, we identify associations between demographic factors and cutaneous eyelid tumour risk.


Skin cancers, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), melanoma, and other cancers, located on the eyelid or canthus according to ICD-10 coding, as registered by the National Cancer Registry of Ireland (NCRI), were captured from the period 2005 to 2015. Age standardised rates (ASR) were calculated according to the European Standard Population (2013). Longitudinal data analysis using linear regression, and associations with age and sex were evaluated with the statistics program R.


There were 4824 patients diagnosed with eyelid BCC during the study period, the ASR in men and women was mean 15.87 and 13.49 per 100,00, respectively. The relative risk for eyelid BCC in men compared with women was 1.18, age was associated with incidence. There were 528 patients diagnosed with SCC; the ASR of eyelid SCC in men and women was 2.10 and 1.39 per 100,000, respectively, and increased in women annually (β = 0.07, p = 0.0005). The relative risk for eyelid SCC in men compared with women was 1.51, and age was exponentially associated with SCC. Melanoma and other eyelid tumours were uncommon—50 and 55 cases, respectively.


Incidence of both BCC and SCC increases with age and male sex. The incidence of eyelid SCC is increasing in women, and under age 50, eyelid BCC is more common in women than men.


We describe the recent incidence of eyelid cancers in Ireland, from National Cancer Registry Data. We find eyelid BCC, and also SCC, are associated with increased age. Rate of eyelid SCC is increasing in women.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Raasch B, Maclennan R, Wronski I, Robertson I. Body site specific incidence of basal and squamous cell carcinoma in an exposed population, Townsville, Australia. Mutat Res. 1998;422:101–6.

  2. 2.

    Green A. Changing patterns in incidence of non-melanoma skin cancer. Epithel Cell Biol. 1992;1:47–51.

  3. 3.

    Salomon J, Bieniek A, Baran E, Szepietowski JC. Basal cell carcinoma on the eyelids: own experience. Dermatol Surg. 2004;30(2 Pt 2):257–63.

  4. 4.

    Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol. 2007;156(Suppl 3):1–7.

  5. 5.

    Soysal HG, Markoc F. Invasive squamous cell carcinoma of the eyelids and periorbital region. Br J Ophthalmol. 2007;91:325–9.

  6. 6.

    Donaldson MJ, Sullivan TJ, Whitehead KJ, Williamson RM. Squamous cell carcinoma of the eyelids. Br J Ophthalmol. 2002;86:1161–5.

  7. 7.

    Tan E, Lin FP, Sheck LH, Salmon PJ, Ng SG. Growth of periocular basal cell carcinomas. Br J Dermatol. 2015;172:1002–7.

  8. 8.

    Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978–2012: empirical relationships. JAMA Dermatol. 2014;150:1063–71.

  9. 9.

    Koh HK, Geller AC, Miller DR, Grossbart TA, Lew RA. Prevention and early detection strategies for melanoma and skin cancer. Current status. Arch Dermatol. 1996;132:436–43.

  10. 10.

    Office CS. Population and Labour Force Projections 2016–2046, 2013.

  11. 11.

    Ireland NCR. Cancer projections for Ireland 2015–2040. Cork, 2014.

  12. 12.

    Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–80.

  13. 13.

    Nikolaou V, Stratigos AJ. Emerging trends in the epidemiology of melanoma. Br J Dermatol. 2014;170:11–9.

  14. 14.

    Excellence NIfHaC. Improving outcomes for people with skin tumours including melanoma. 2006.

  15. 15.

    Ireland NCR. About us. 2018. Accessed 18 May 2018.

  16. 16.

    Office CS. Population and migration estimates April 2016, 2016.

  17. 17.

    Organization WH. International Classification of Diseases for Oncology., 3rd ed. Topographical Codes. 2018. Accessed 18 May 2018.

  18. 18.

    Team RC. R: A language and environment for statistical computing. 2016.

  19. 19.

    Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev. 2015;24:141–9.

  20. 20.

    Saleh GM, Desai P, Collin JR, Ives A, Jones T, Hussain B. Incidence of eyelid basal cell carcinoma in England: 2000–2010. Br J Ophthalmol. 2017;101:209–12.

  21. 21.

    Wawrzynski J, Tudge I, Fitzgerald E, et al. Report on the incidence of squamous cell carcinomas affecting the eyelids in England over a 15-year period (2000–2014). Br J Ophthalmol. 2018;102:1358–61.

  22. 22.

    Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjaer SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer. 2010;127:2190–8.

  23. 23.

    Purdue MP, Freeman LE, Anderson WF, Tucker MA. Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol. 2008;128:2905–8.

  24. 24.

    de Vries E, Louwman M, Bastiaens M, de Gruijl F, Coebergh JW. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol. 2004;123:634–8.

  25. 25.

    Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294:681–90.

  26. 26.

    Bath-Hextall F, Leonardi-Bee J, Smith C, Meal A, Hubbard R. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer. 2007;121:2105–8.

  27. 27.

    McLean DI, Phillips N, Zhou Y, Gallagher R, Lee TK. 40-year trends in skin cancer in British Columbia, Canada, 1973 to 2003. J Cutan Med Surg. 2012;16:83–91.

  28. 28.

    Hoey SE, Devereux CE, Murray L, et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br J Dermatol. 2007;156:1301–7.

  29. 29.

    Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008. Eur J Cancer. 2012;48:2046–53.

  30. 30.

    Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10.

  31. 31.

    Levell NJ, Igali L, Wright KA, Greenberg DC. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin Exp Dermatol. 2013;38:367–9.

  32. 32.

    Goodwin RG, Holme SA, Roberts DL. Variations in registration of skin cancer in the United Kingdom. Clin Exp Dermatol. 2004;29:328–30.

  33. 33.

    Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol. 2017;177:359–72.

  34. 34.

    Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015;54:130–40.

  35. 35.

    Society AC. Cancer facts & figures. Atlanta; 2003.

  36. 36.

    Ireland NCR. Cancer Trends no 20. Non-melanoma skin cancer. 2013.

Download references

Author information


  1. Sligo University Hospital, Sligo, Ireland

    • Clare Quigley
    • , Emily Hughes
    •  & Shivona Chetty
  2. National Cancer Registry Ireland, Cork Airport Business Park, Cork, Ireland

    • Sandra Deady
  3. Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia

    • Elizabeth McElnea
  4. Department of Public Health & Primary Care, Trinity College Dublin, Dublin, Ireland

    • Lina Zgaga


  1. Search for Clare Quigley in:

  2. Search for Sandra Deady in:

  3. Search for Emily Hughes in:

  4. Search for Elizabeth McElnea in:

  5. Search for Lina Zgaga in:

  6. Search for Shivona Chetty in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Clare Quigley.

About this article

Publication history